Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301

Search this article

Journal

Citations (2)*help

See more

References(39)*help

See more

Details 詳細情報について

Report a problem

Back to top